Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
Datta A, Adelson ME, Mogilevkin Y, Mordechai E, Sidi AA, Trama JP.
BMC Cancer. 2011 Jun 10;11:234.
Related citations
Adenoviral infectivity of exfoliated viable cells in urine: implications for the detection of bladder cancer.
Murali A, Kasman L, Voelkel-Johnson C.
BMC Cancer. 2011 May 12;11:168.
Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.
Yeh CY, Shin SM, Yeh HH, Wu TJ, Shin JW, Chang TY, Raghavaraju G, Lee CT, Chiang JH, Tseng VS, Lee YC, Shen CH, Chow NH, Liu HS.
BMC Cancer. 2011 Apr 16;11:139.
Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer.
Nordentoft I, Dyrskjøt L, Bødker JS, Wild PJ, Hartmann A, Bertz S, Lehmann J, Orntoft TF, Birkenkamp-Demtroder K.
BMC Cancer. 2011 Apr 14;11:135.
The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
Rouissi K, Bahria IB, Bougatef K, Marrakchi R, Stambouli N, Hamdi K, Cherif M, Ben Slama MR, Sfaxi M, Othman FB, Chebil M, Elgaaied AB, Ouerhani S.
BMC Cancer. 2011 Mar 22;11:101.
Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study.
Abdel Raheem AM, Hameed DA, ElGanainy EO, Mosad E, Abdelwanis ME, Kamel NA, Hammouda HM, Abdelaziz MA, Hemeyda K.
BMC Cancer. 2011 Jan 12;11:16.
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.
Brems-Eskildsen AS, Zieger K, Toldbod H, Holcomb C, Higuchi R, Mansilla F, Munksgaard PP, Borre M, Ørntoft TF, Dyrskjøt L.
BMC Cancer. 2010 Nov 24;10:646.
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells.
Karkoulis PK, Stravopodis DJ, Margaritis LH, Voutsinas GE.
BMC Cancer. 2010 Sep 9;10:481.
Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.
Marra E, Uva P, Viti V, Simonelli V, Dogliotti E, De Rinaldis E, Lahm A, La Monica N, Nicosia A, Ciliberto G, Palombo F.
BMC Cancer. 2010 Apr 7;10:129.
Functional significance of the hepaCAM gene in bladder cancer.
He Y, Wu X, Luo C, Wang L, Lin J.
BMC Cancer. 2010 Mar 8;10:83.
Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer.
Kim SK, Kim EJ, Leem SH, Ha YS, Kim YJ, Kim WJ.
BMC Cancer. 2010 Jan 25;10:21.
Bladder metastases of appendiceal mucinous adenocarcinoma: a case presentation.
Taverna G, Corinti M, Colombo P, Grizzi F, Severo M, Piccinelli A, Giusti G, Benetti A, Zucali PA, Graziotti P.
BMC Cancer. 2010 Feb 23;10:62.
Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.
Del Rey J, Prat E, Ponsa I, Lloreta J, Gelabert A, Algaba F, Camps J, Miró R.
BMC Cancer. 2010 Jun 11;10:280.
Robust assignment of cancer subtypes from expression data using a uni-variate gene expression average as classifier.
Lauss M, Frigyesi A, Ryden T, Höglund M.
BMC Cancer. 2010 Oct 6;10:532.
Molecular targets for the protodynamic action of cis-urocanic acid in human bladder carcinoma cells.
Peuhu E, Kaunisto A, Laihia JK, Leino L, Eriksson JE.
BMC Cancer. 2010 Oct 3;10:521.
Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.
Tseng YS, Lee JC, Huang CY, Liu HS.
BMC Cancer. 2009 Dec 12;9:435.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on